WFA
IRMD icon

Wipfli Financial Advisors’s iRadimed IRMD Stock Holding History

Wipfli Financial Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$0 Buy
+6
New +$209 ﹤0.01% 2585

Other funds holding IRMD

NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BCM
Bares Capital Management Austin, Texas $1.08B AUM 38.13% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wipfli Financial Advisors's IRMD Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in iRadimed (IRMD) in Q3 2022: 6 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #2585 among its holdings.

86 funds tracked by Wall St. Rank hold IRMD as of Q3 2022.

  • Wipfli Financial Advisors held 6 shares of iRadimed worth $0 as of Q3 2022.
  • iRadimed was a new Wipfli Financial Advisors position in Q3 2022.
  • iRadimed made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #2585 holding.
  • 86 funds tracked by Wall St. Rank held iRadimed as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.